New drug combo shows promise in shrinking esophageal tumors before surgery
NCT ID NCT04974047
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tested whether giving the immunotherapy drug tislelizumab together with chemotherapy or chemoradiotherapy before surgery could help people with a certain type of esophageal cancer. About 70 adults with resectable esophageal squamous cell carcinoma took part. The main goal was to see how many had no cancer left in the removed tissue after the combined treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
Anhui Provincial Hospital
Hefei, Anhui, 230000, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
-
Tangdu Hospital
Xi'an, Shaanxi, 710038, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300060, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.